NCT03922880 2025-05-15Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal MelanomaMemorial Sloan Kettering Cancer CenterPhase 1 Completed9 enrolled
NCT01665183 2016-02-25Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic MelanomaPolaris GroupPhase 1 Completed8 enrolled